Sarah Boyce's Net Worth

Sarah Boyce's net worth is estimated to be at least $14,540,946.37 as of 11/08/2024. CoreStreet's estimation of Sarah Boyce's net worth is based on their sale of stock and current holding of stock.

Sarah Boyce is CEO at Avidity Biosciences Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 32,880 units of RNA stock on 09/23/2024. Their biggest sale was on 06/13/2024 when they sold 164,233 units of Avidity Biosciences Inc stock for $6,582,458.64. They typically trade 2 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $14,540,946.37
Most recent insider trade:
  • Sept. 23, 2024

Sarah Boyce's Insider Trading History

Avidity Biosciences IncTitleAmountPriceTypeTotal Value
Sept. 23, 2024
CEO32,880$44.00Sell$1,446,720.00
Aug. 6, 2024
CEO28,000$43.35Sell$1,213,800.00
July 9, 2024
CEO28,000$39.93Sell$1,118,040.00
June 13, 2024
CEO164,233$40.08Sell$6,582,458.64
June 4, 2024
CEO28,000$27.42Sell$767,760.00
May 7, 2024
CEO28,000$25.54Sell$715,120.00
March 12, 2024
CEO28,000$22.63Sell$633,640.00
March 8, 2024
CEO84,000$21.39Sell$1,796,760.00
Jan. 22, 2024
CEO5,092$10.13Sell$51,581.96
Aug. 15, 2022
CEO100$22.47Sell$2,247.00
Ionis Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Jan. 16, 2018
Insider2,196$51.76Sell$113,664.96
Jan. 17, 2017
Insider1,361$46.29Sell$63,000.69
Jan. 19, 2016
insider872$41.46Sell$36,153.12